Next 10 |
home / stock / evo / evo articles
U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Thursday. Shares of Delta Air Lines, Inc. (NYSE:DAL) fel...
German drug developer Evotec SE (NASDAQ:EVO) is reportedly consulting defense advisers following a significant drop in share price, raising concern...
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endp...
U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday. Shares of AMC Networks Inc. (NASDAQ:AMCX) fell...
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday. The Dow traded down 0.18% to 38,434.99...
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday. The Dow traded down 0.33% to 38,376.53 wh...
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday. Following the market opening Wednesday, the Dow ...
European life science company Evotec SE (NASDAQ:EVO) announced a priority reset to optimize its business to meet evolving marke...
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results. Tesla posted weaker-than-expec...
News, Short Squeeze, Breakout and More Instantly...
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG, GERMANY / ACCESSWIRE / July 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(NASDAQ:EVO) (MDAX/TecDAX , ISIN: DE0005664809) today announced it has entered into a mul...
Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term commercial supply security HAMBURG, GERMANY...
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...